Table 2.
Correlations of arterial AcAc, β-HB, and AcAc/β-HB ratio in non-DM and T2DM HD patients
| All HD patients (n = 49) | Non-DM group (n = 24) | T2DM group (n = 25) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| AcAc | β-HB | AcAc/β-HB | AcAc | β-HB | AcAc/β-HB | AcAc | β-HB | AcAc/β-HB | |
| Age | 0.092 | 0.035 | −0.039 | 0.016 | −0.118 | 0.063 | 0.219 | 0.358 | −0.317 |
| BMI | −0.023 | − 0.068 | 0.160 | − 0.024 | − 0.214 | 0.268 | − 0.014 | − 0.180 | 0.327 |
| HD duration | 0.043 | −0.162 | 0.190 | −0.043 | − 0.099 | 0.096 | 0.228 | 0.020 | 0.000 |
| Interdialytic BW gain | −0.243 | −0.472 | 0.360* | −0.228 | − 0.453* | 0.302 | − 0.218 | −0.420* | 0.357 |
| Serum urea nitrogen | −0.095 | −0.350 | 0.434* | −0.020 | − 0.414* | 0.458* | − 0.130 | −0.282 | 0.467* |
| Cre | −0.031 | −0.267 | 0.343* | −0.078 | − 0.373 | 0.425* | 0.073 | −0.108 | 0.254 |
| Alb | 0.140 | 0.021 | 0.112 | −0.052 | −0.352 | 0.442* | 0.308 | 0.235 | −0.030 |
| Fasting plasma glucose | 0.196 | −0.013 | 0.207 | 0.143 | −0.408* | 0.592* | 0.165 | 0.013 | 0.177 |
| Glycoalbumin | 0.088 | 0.166 | −0.163 | −0.038 | − 0.338 | 0.342 | − 0.002 | 0.230 | − 0.318 |
| LDL-C | 0.054 | 0.193 | −0.231 | 0.302 | 0.477* | −0.467* | −0.210 | − 0.005 | −0.137 |
| Uric acid | 0.057 | −0.296 | 0.474* | 0.083 | −0.477* | 0.664* | 0.111 | 0.036 | 0.139 |
| Pi | −0.338* | −0.242 | 0.204 | −0.535* | − 0.109 | −0.009 | − 0.137 | −0.304 | 0.445* |
Correlation (r) was examined using Spearman’s Rank Correlation test
*Statistically significant difference (p < 0.05)